📄 medicine

Association Between ABO Blood Group and Self-Reported Recovery from Infectious Diseases Among University Students in Anuradhapura District, Sri Lanka

This cross-sectional study of 322 university students in Sri Lanka found no statistically significant association between ABO blood groups and self-reported recovery outcomes from infectious diseases, despite a notable over-representation of blood group O in the sample.

Original authors: Rishmi Sri Wijebandara

Published 2026-08-04

📖 4 min read☕ Coffee break read

CC BY 4.0

Original authors: Rishmi Sri Wijebandara

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ✨ This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

Imagine your body as a bustling city, and your immune system as the tireless police force keeping the streets safe. For years, scientists have wondered if the "badge" on every citizen's uniform—specifically, their ABO blood type (A, B, AB, or O)—acts like a special ID card that makes them more or less likely to catch a germ or bounce back from a sickness. Think of blood types like different flavors of ice cream; some people think vanilla (Group O) might be better at fending off a cold than chocolate (Group A), while others suspect the rare mint-chip (Group AB) might struggle more. This idea has been buzzing around since the pandemic, with some studies suggesting your blood type could be a secret weapon or a weak spot. But here's the catch: most of these studies happened in big hospitals with very sick people. We didn't really know if this "blood type magic" worked for regular folks, especially young students living in dorms or shared houses, dealing with everyday bugs like the flu or dengue. That's the mystery this paper set out to solve: does your blood type actually dictate how fast you recover from getting sick, or is that just a myth we tell ourselves?

The researchers in Anuradhapura, Sri Lanka, decided to play detective with 322 university students. They asked these students to look back over the last five years and report on any infectious diseases they'd had—things like COVID-19, dengue, or the flu—and how they felt while recovering. They wanted to see if there was a pattern: Did the "O" students get better faster? Did the "AB" students get sicker? Did students with certain blood types rush to the hospital more often?

Here is the twist in the story: The data revealed a massive surprise about who was in the room, but a very boring answer about what happened to them. First, the team found that their group of students was wildly unbalanced when it came to blood types. While the general population of Sri Lanka is expected to have a mix of about 35% Group O, this student crowd was packed with Group O folks—62.4% of them! It was like walking into a room expecting a mix of ice cream flavors and finding that nearly two-thirds of the people were eating vanilla. This huge difference was statistically significant, suggesting that this specific group of students might have a unique genetic makeup or that the area they live in has a lot of Group O people.

However, when the researchers asked the big question—"Does your blood type change how you recover?"—the answer was a resounding "No." They checked everything: how severe the symptoms were, how long it took to feel better, whether the sickness came back (relapse), and if students had to go to the hospital. They compared the recovery times of Group A, B, AB, and O students. The results showed that the differences between the groups were so tiny they could easily be chalked up to random chance. It's like flipping a coin 300 times and finding that "Heads" and "Tails" come up almost exactly the same number of times, regardless of whether you're wearing a red shirt or a blue shirt.

In fact, the study found that the students' own beliefs didn't match the reality either. About 41% of the students thought their blood type did influence their recovery, but the numbers showed no link at all. The only thing that seemed to matter for how students acted was how bad their symptoms felt. If a student felt terrible, they sought help; if they felt okay, they stayed home. Their blood type didn't seem to be the boss of that decision.

So, what's the takeaway? While this study confirmed that this specific group of students has a very high number of Group O individuals—which is useful info for local blood banks to know so they can plan their supplies—it suggests that for everyday recovery from infections, your blood type isn't the magic switch we thought it might be. The author is careful to say they didn't prove blood type has zero effect in the entire universe, but in this group of students, with this mix of diseases, the effect was too small to measure. It seems that when it comes to getting over a cold or the flu, your immune system's daily grind and how sick you feel matter much more than the letter on your blood type badge.

Technical Summary: Association Between ABO Blood Group and Self-Reported Recovery from Infectious Diseases Among University Students in Anuradhapura District, Sri Lanka

Problem Statement

While existing literature has established links between ABO blood groups and susceptibility or severity in specific infectious diseases (e.g., Plasmodium falciparum malaria, SARS-CoV-2), evidence regarding recovery outcomes in South Asian, non-clinical populations is scarce. Most prior research focuses on hospitalized cohorts in high-income settings or addresses susceptibility rather than the duration and trajectory of recovery. Furthermore, no published Sri Lankan study has investigated whether ABO blood group correlates with self-reported recovery metrics (duration, severity, relapse, hospitalization) among university students. This study addresses these gaps by examining the relationship between blood type and recovery outcomes in a community-based student population in the Anuradhapura District, while also comparing the sample's blood group distribution against national norms.

Methodology

Study Design and Population:
The research employed a cross-sectional survey design targeting university students aged 18 and above residing in the Anuradhapura District (primarily from Rajarata University, Open University, and Bhiksu University). The target population was approximately 13,500 students.

Sampling and Data Collection:

Sample Size: A target of 374 was calculated using Cochran's formula; however, 322 valid responses were obtained (86% of target) due to recruitment challenges.
Eligibility: Participants must have had at least one self-identified infectious disease (e.g., COVID-19, dengue, influenza) within the preceding five years and must know their ABO blood group.
Instrument: A structured questionnaire collected data on demographics, self-reported blood group, and recovery outcomes (duration, symptom severity, progression, relapse, hospitalization level).
Data Verification: All disease history and blood group data were self-reported. No clinical records or laboratory confirmations were reviewed. Blood group knowledge was derived from prior tests (49.1%) or self-identification.
Distribution: Data was collected via Google Forms and paper questionnaires between January and June 2025 to ensure reach across digital and non-digital demographics.

Statistical Analysis:
Data were analyzed using IBM SPSS Statistics (v29).

Distribution Analysis: A $\chi^2$ goodness-of-fit test compared the sample's blood group distribution against published Sri Lankan national norms (A=25%, B=30%, AB=10%, O=35%).
Association Testing: Chi-square tests of independence assessed relationships between blood group and categorical recovery outcomes (severity, progression, relapse, hospitalization). Cramer's $V$ was used for effect size.
Continuous Variable Analysis: One-way ANOVA with Tukey HSD post-hoc comparisons tested for differences in mean recovery time across blood groups. $\eta^2$ was reported as the effect size.
Significance Level: Set at $\alpha = 0.05$ .

Key Results

1. Blood Group Distribution:
The sample exhibited a statistically significant deviation from national norms ( $\chi^2(3) = 125.490, p < 0.0001$ , Cohen's $w = 0.62$ ).

Observed: Group O was markedly over-represented at 62.4% (n=201), while Groups A (16.5%), B (14.6%), and AB (6.5%) were under-represented.
Implication: This suggests regional genetic structuring or demographic concentration within the sampled institutions, independent of recovery outcomes.

2. Association with Recovery Outcomes:
No statistically significant associations were found between ABO blood group and any recovery-related outcome:

Symptom Severity: $\chi^2(12) = 5.475, p = 0.940$ (Cramer's $V = 0.075$ ).
Recovery Time (Categorical): $\chi^2(12) = 5.935, p = 0.919$ (Cramer's $V = 0.078$ ).
Symptom Progression: $\chi^2(6) = 7.176, p = 0.305$ (Cramer's $V = 0.106$ ).
Relapse/Persistence: $\chi^2(6) = 8.376, p = 0.212$ (Cramer's $V = 0.114$ ).
Hospitalization Level: $\chi^2(9) = 6.508, p = 0.688$ (Cramer's $V = 0.082$ ).
Perceived Influence: Beliefs about blood type affecting recovery did not vary by actual blood group ( $\chi^2(6) = 6.692, p = 0.350$ ).

3. Mean Recovery Time:
One-way ANOVA revealed no significant difference in mean recovery duration across blood groups ( $F(3, 318) = 1.231, p = 0.299, \eta^2 = 0.011$ ).

While descriptive trends showed Group O with the shortest mean recovery (2.46 weeks) and Group AB the longest (2.95 weeks), these differences were not statistically significant. The variance within groups was substantially larger than the variance between groups.

Key Contributions

Regional Evidence: This study provides the first Sri Lankan data specifically linking ABO blood groups to self-reported recovery outcomes in a community-based student population, filling a gap in South Asian literature.
Methodological Approach: It utilizes a mixed-mode survey (digital and paper) to capture a diverse student demographic and explicitly tests recovery metrics (duration, relapse) often neglected in favor of susceptibility or severity studies.
Practical Utility: The identification of a significant over-representation of Blood Group O (62.4%) in this specific district offers actionable data for regional blood bank planning and donor recruitment strategies.

Significance and Claims

The paper concludes that in this specific sample, ABO blood group is not a statistically reliable predictor of self-reported recovery outcomes from infectious diseases. The study explicitly claims:

Null Findings are Robust: The consistent lack of significance across five independent outcome variables, coupled with small effect sizes, suggests the absence of association is genuine rather than solely a result of low statistical power, though power limitations for smaller subgroups (e.g., AB) are acknowledged.
Drivers of Behavior: Healthcare-seeking behavior and perceived recovery appear to be driven more strongly by perceived symptom severity and psychosocial factors (consistent with the Common-Sense Model of self-regulation) than by biological blood type.
Limitations on Generalizability: The author cautions that the pooling of heterogeneous infectious diseases (COVID-19, dengue, influenza) may have diluted disease-specific associations. Additionally, the reliance on self-reported data and the cross-sectional design preclude causal inference.
Future Direction: The study does not support using blood group as a standalone predictor for student health planning in this setting. It suggests that future research should prioritize larger, multi-regional samples with clinically confirmed diagnoses and disease-stratified analyses to detect potential smaller effects.